683611000001105: Methotrexate 2.5mg tablets (Wyeth Laboratories) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\UK product\Virtual medicinal product\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\UK product\Virtual therapeutic moiety\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\UK product\Virtual therapeutic moiety\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing methotrexate\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing methotrexate\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing methotrexate\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing pteridine\Product containing methotrexate\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing pteridine\Product containing methotrexate\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by structure\Product containing pteridine\Product containing methotrexate\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing methotrexate\Methotrexate\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing methotrexate\Methotrexate\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing methotrexate\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)
\Medicinal product\Product manufactured as oral dose form\Product containing methotrexate in oral dose form (medicinal product form)\Product containing only methotrexate in oral dose form (medicinal product form)\Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet\Methotrexate 2.5mg tablets (Wyeth Laboratories)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17071301000001117 Methotrexate 2.5mg tablets (Wyeth Laboratories) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

111522201000001114 Methotrexate 2.5mg tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Is a	Product containing precisely methotrexate 2.5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has excipient	Excipient not declared	false	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has active ingredient	Methotrexate	false	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has specific active ingredient	Methotrexate	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Methotrexate 2.5mg tablets (Wyeth Laboratories) 28 tablet 2 x 14 tablets	Is pack of	False	Methotrexate 2.5mg tablets (Wyeth Laboratories)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Goldshield Pharmaceuticals Ltd) 24 tablet 2 x 12 tablets	Is pack of	False	Methotrexate 2.5mg tablets (Wyeth Laboratories)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Goldshield Pharmaceuticals Ltd) 24 tablet 2 x 12 tablets	Has AMP	True	Methotrexate 2.5mg tablets (Wyeth Laboratories)	Inferred relationship	Existential restriction modifier
Methotrexate 2.5mg tablets (Wyeth Laboratories) 28 tablet 2 x 14 tablets	Has AMP	True	Methotrexate 2.5mg tablets (Wyeth Laboratories)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17071301000001117	Methotrexate 2.5mg tablets (Wyeth Laboratories) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
111522201000001114	Methotrexate 2.5mg tablets (Advanz Pharma)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module